You limited your search to:

 Collection: Congressional Research Service Reports
Attorneys' Fees in the State Tobacco Litigation Cases

Attorneys' Fees in the State Tobacco Litigation Cases

Date: September 23, 1997
Creator: Contrubis, John
Description: In the past few years, many states have filed complaints against the tobacco industry in state court to recover Medicaid costs paid by the states to treat their citizens for tobacco related illnesses. The states are also attempting to recover other damages, such as punitive damages, against the tobacco industry. For various reasons, the states have hired private attorneys to assist the state Attorneys General in prosecuting these cases. In most cases, the retention of private counsel has included a fee agreement specifying the amount of compensation that these attorneys will receive for their services. These agreements are not uniform among the states, but most tend to provide some form of contingency fee arrangement. Some of these states have developed a sliding scale contingency fee schedule which varies with the amount of time spent on the litigation and whether a trial has begun. This report briefly summarizes the different fee agreements that the states have with private counsel.
Contributing Partner: UNT Libraries Government Documents Department
Authorized Generic Pharmaceuticals: Effects on Innovation

Authorized Generic Pharmaceuticals: Effects on Innovation

Date: August 8, 2006
Creator: Thomas, John R
Description: The practice of “authorized generics” has recently been the subject of considerable attention by the pharmaceutical industry, regulators, and members of Congress alike. An “authorized generic”–sometimes termed a “branded,” “flanking,” or “pseudo” generic–is a pharmaceutical that is marketed by or on behalf of a brand name drug company, but is sold under a generic name. Although the availability of an additional competitor in the generic drug market would appear to be favorable to consumers, authorized generics have nonetheless proven controversial. Some observers believe that authorized generics potentially discourage independent generic firms both from challenging drug patents and from selling their own products.
Contributing Partner: UNT Libraries Government Documents Department
Automobile Domestic Content Requirements

Automobile Domestic Content Requirements

Date: May 18, 1982
Creator: Nanto, Dick K
Description: In response to the lowest drop of American produced automobile sales in two decades and other related conditions, legislation has been introduced that would impose domestic (local) content ratios for automotive vehicles. These would require that cars and trucks sold in the United States in large quantities contain a certain percentage of American parts and labor.
Contributing Partner: UNT Libraries Government Documents Department
Bankruptcy and Business Failure Data

Bankruptcy and Business Failure Data

Date: August 20, 1982
Creator: Scott, Oscar
Description: The purpose of this report is to provide statistical data on the actual number of businesses that are filing for bankruptcy or ceasing operations. Tabular data of both a historical and current nature concerning business failures and bankruptcies is provided.
Contributing Partner: UNT Libraries Government Documents Department
Biomass Feedstocks for Biopower: Background and Selected Issues

Biomass Feedstocks for Biopower: Background and Selected Issues

Date: October 6, 2010
Creator: Bracmort, Kelsi
Description: The production of bioenergy - renewable energy derived from biomass - could potentially increase national energy security, reduce greenhouse gas emissions, and contribute to rural economic growth. This report provides analyses of commonly discussed biomass feedstocks and their relative potential for power generation. Additional biopower issues - feedstock accessibility, the biomass power plant carbon-neutrality debate, and unintended consequences of legislative activities to promote bioenergy - are also discussed.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: June 30, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: July 23, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: September 8, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
A Brief Overview of Business Types and Their Tax Treatment

A Brief Overview of Business Types and Their Tax Treatment

Date: June 12, 2013
Creator: Keightley Mark P.
Description: Report that provides a general overview of the tax treatment of the major business types, including sole proprietorships, partnerships, C corporations, subchapter S corporations, and limited liability companies.
Contributing Partner: UNT Libraries Government Documents Department
Budget Deficits: Causes, Effects and Some Remedial Options

Budget Deficits: Causes, Effects and Some Remedial Options

Date: July 15, 1985
Creator: Grinnell, David & Cox, William A
Description: In 1981 Congress enacted extensive changes in taxing and spending policies that supporters of these changes expected to generate sufficient revenues, despite a series of tax rate cuts, to balance the budget by FY84. After the onset of recession in early 1982, however, the Reagan Administration's projections showed widening budget deficits, which culminated in an actual FY83 deficit of $195.4 billion. Despite enactment of the Tax Equity and Fiscal Responsibility Act of 1982, and, more recently, the Deficit Reduction Act of 1984, large deficits are expected to persist, even under continued favorable economic conditions, unless Federal taxing and spending policies are altered dramatically.
Contributing Partner: UNT Libraries Government Documents Department